Barclays
ACH

Barclays’s Accendra Health ACH Stock Holding History

Barclays’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-106,300
Closed -$2.95M – 5181
2024
Q1 		$2.95M Buy
+106,300
New +$2.36M ﹤0.01% 2249

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Barclays's ACH Position: Q2 2026 in Review

Barclays reduced its Accendra Health (ACH) stake by 35% in Q2 2026, selling an estimated $16.6K and leaving 9,939 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #4443.

Barclays first reported a position in ACH in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.14M in Q1 2021. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Barclays held 9,939 shares of Accendra Health worth $34K as of Q2 2026.
  • Barclays sold 5,339 Accendra Health shares in Q2 2026, an estimated $16.6K.
  • Accendra Health made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4443 holding.
  • Barclays first reported a position in Accendra Health in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Accendra Health position peaked at $6.14M in Q1 2021.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.